NCT02121860View on ClinicalTrials.gov

PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Hepatic ImpairmentLiver DiseasesDigestive System Diseases
Interventions
DRUG

IDN-6556

Trial Locations (3)

32720

Avail Clinical Research, DeLand

32809

Orlando Clinical Research Center, Orlando

33136

University of Miami, Miami

Sponsors
All Listed Sponsors
lead

Conatus Pharmaceuticals Inc.

INDUSTRY

NCT02121860 - PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers | Biotech Hunter | Biotech Hunter